For: | Rajesh S, Cox MJ, Runau F. Molecular advances in pancreatic cancer: A genomic, proteomic and metabolomic approach . World J Gastroenterol 2021; 27(31): 5171-5180 [PMID: 34497442 DOI: 10.3748/wjg.v27.i31.5171] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v27/i31/5171.htm |
Number | Citing Articles |
1 |
Aleksander M. Bogdanski, Jeanin E. van Hooft, Bas Boekestijn, Bert A. Bonsing, Martin N. J. M. Wasser, Derk C. F. Klatte, Monique E. van Leerdam. Aspects and outcomes of surveillance for individuals at high-risk of pancreatic cancer. Familial Cancer 2024; 23(3): 323 doi: 10.1007/s10689-024-00368-1
|
2 |
Hiroki Ohya, Kentaro Miyake, Hironori Fukuoka, Masanori Oshi, Atsushi Ishibe, Koji Narita, Ken Kasahara, Itaru Endo. SLC7A11 and the glutathione pathway as novel prognostic markers in resectable pancreatic ductal adenocarcinoma: A metabolomics study of clinical specimens. Pancreatology 2024; 24(5): 779 doi: 10.1016/j.pan.2024.05.530
|
3 |
Simran Arjani, Vishnu Prasath, Nipun Suri, Sharon Li, Sushil Ahlawat, Ravi J. Chokshi. Neoadjuvant Treatment Versus Upfront Surgery in Resectable Pancreatic Cancer: A Cost-Effectiveness Analysis. JCO Oncology Practice 2023; 19(3): e439 doi: 10.1200/OP.22.00536
|
4 |
Chaodong Huang, Yufeng Chen, Bingtao Li, Qiyun Zhang, Li Jiang, Bin Nie, Lihua Chen, Hui Jian, Guoliang Xu, Vuanghao Lim. Traditional Chinese Medicine Constitution Discrimination Model Based on Metabolomics and Random Forest Decision Tree Algorithm. Evidence-Based Complementary and Alternative Medicine 2022; 2022: 1 doi: 10.1155/2022/3490130
|